Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1160.57/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57 |
| Version | 20241016 |
| Status | active |
| Date | 2024-10-16T01:07:54-04:00 |
| Name | AldosteroneReceptorBlockerForHypertension |
| Title | Aldosterone Receptor Blocker for Hypertension |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Aldosterone Receptor Blocker pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Aldosterone Receptor Blocker pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Aldosterone Receptor Blocker pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1160.57",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2024-11-26T11:15:08.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "HSAG Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-16"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-10-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.57",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1160.57"
}
],
"version" : "20241016",
"name" : "AldosteroneReceptorBlockerForHypertension",
"title" : "Aldosterone Receptor Blocker for Hypertension",
"status" : "active",
"date" : "2024-10-16T01:07:54-04:00",
"publisher" : "American Medical Association Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Aldosterone Receptor Blocker pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Aldosterone Receptor Blocker pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Aldosterone Receptor Blocker pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "104232",
"display" : "spironolactone 5 MG/ML Oral Suspension"
},
{
"code" : "198222",
"display" : "spironolactone 100 MG Oral Tablet"
},
{
"code" : "198223",
"display" : "spironolactone 50 MG Oral Tablet"
},
{
"code" : "198224",
"display" : "hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet"
},
{
"code" : "198225",
"display" : "hydrochlorothiazide 50 MG / spironolactone 50 MG Oral Tablet"
},
{
"code" : "313096",
"display" : "spironolactone 25 MG Oral Tablet"
},
{
"code" : "351256",
"display" : "eplerenone 25 MG Oral Tablet"
},
{
"code" : "351257",
"display" : "eplerenone 50 MG Oral Tablet"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:234b9af3-879f-4ef0-b5a5-8c1503728fa8",
"timestamp" : "2024-12-10T07:17:13-05:00",
"total" : 8,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "104232",
"display" : "spironolactone 5 MG/ML Oral Suspension"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198222",
"display" : "spironolactone 100 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198223",
"display" : "spironolactone 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198224",
"display" : "hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198225",
"display" : "hydrochlorothiazide 50 MG / spironolactone 50 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313096",
"display" : "spironolactone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351256",
"display" : "eplerenone 25 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "351257",
"display" : "eplerenone 50 MG Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR